GBA1 and Parkinson disease: Thus, researchers focus on identifying symptom-based (both motor and non-motor) PD subtypes and genetic subtypes, such as those associated with mutations in glucocerebrosidase (GBA1) or leucine-rich repeat kinase 2 (LRRK2) (Sardi et al., 2018).